EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

A biparatopic HER2-targeting ADC constructed via site-specific glycan conjugation exhibits superior stability, safety, and efficacy

Qi Xue iD, Jianjian Peng, Wenying Dai, Qingsong Wu, Jinbiao Jiao, Yudi Hu, Wanxing Sha, Yang Yang, Wenhao Yu, Siyang Liu, Ting Xu, Jie P Li iD

RSC Chemical Biology · 2025 · 6 (8) · 1284-1296

DOI: 10.1039/d5cb00096c ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Chemical Biology, 2025. Verfasst von Qi Xue und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), …. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Natural Science Foundation of Jiangsu Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Site-specific glycan conjugation enables a stable and efficacious biparatopic HER2-targeting ADC.

Autor:innen und Institutionen

  • State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University Nanjing China jieli@nju.edu.cn.
  • Jiangsu Alphamab Biopharmaceuticals Co., Ltd. BioBay Building C23 218 Xinghu Street Suzhou Industrial Park Suzhou Jiangsu China tingxu@alphamabonc.com.

ORCID-Profile: Qi Xue, Jie P Li

Förderung

  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Xue, Q., Peng, J., Dai, W., Wu, Q., Jiao, J., Hu, Y., Sha, W., Yang, Y., Yu, W., Liu, S., Xu, T., & Li, J. P. (2025). A biparatopic HER2-targeting ADC constructed via site-specific glycan conjugation exhibits superior stability, safety, and efficacy. RSC Chemical Biology, 6(8), 1284-1296. https://doi.org/10.1039/d5cb00096c

Vancouver

Xue Q, Peng J, Dai W, Wu Q, Jiao J, Hu Y, et al. A biparatopic HER2-targeting ADC constructed via site-specific glycan conjugation exhibits superior stability, safety, and efficacy. RSC Chemical Biology. 2025;6(8):1284-1296. doi:10.1039/d5cb00096c

BibTeX
@article{Xue2025,
  author = {Xue, Qi and Peng, Jianjian and Dai, Wenying and Wu, Qingsong and Jiao, Jinbiao and Hu, Yudi and Sha, Wanxing and Yang, Yang and Yu, Wenhao and Liu, Siyang and Xu, Ting and Li, Jie P},
  title = {A biparatopic HER2-targeting ADC constructed via site-specific glycan conjugation exhibits superior stability, safety, and efficacy},
  journal = {RSC Chemical Biology},
  year = {2025},
  volume = {6},
  number = {8},
  pages = {1284--1296},
  doi = {10.1039/d5cb00096c}
}
Kostenlos starten →